NeoGel will train researchers in an academia-industry collaboration where the joint objective will be to create a new hydrogel platform technology. In next-generation biomedicine smart resorbable hydrogels will play a key role, for instance as platform materials for tissue engineering. These materials have potential to address a wide range of medical conditions. To explore this opportunity and exploit the potential, highly-qualified and well trained biomaterials experts are urgently required.
NeoGel will build on the unique combination of skills and technology in polymer chemistry, biomaterials science, advanced biomedical fabrication methods and medical technology, combined with commercialization aspects available across the collaborators.
The overall objective is to train Early Stage Researchers (ESRs) with the multidisciplinary thinking, planning ability and drive required to operate in a challenging field and to provide a lead for Europe in biomedical materials. This will be achieved through the development of a new biomaterials technology platform.
"Working with the accelopment team was truly inspiring. As scientist we know how to write a good scientific proposal but accelopment lifts it up in terms of focus and quality."
Dr Andreas Heise, Dublin City University, IE